The Efficacy and Safety of Dalfampridine on Cognition and Fatigue in People With Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Background Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system. People with MS frequently experience cognitive dysfunction and fatigue. Dalfampridine (DAL), a potassium channel blocker, is US Food and Drug Administration-approved for the treatment of walking impairment in people...